Read + Share
Kim SH, Im SA, Suh KJ, Lee KH, et al. Clinical activity of nivolumab in combination with eribulin in HER2-negative
metastatic breast cancer: A phase IB/II study (KCSG BR18-16). Eur J Cancer 2023;195:113386.
PMID: 37890351
|
 |
|
Kim SH, Im SA, Suh KJ, Lee KH, et al. Clinical activity of nivolumab in combination with eribulin in HER2-negative
metastatic breast cancer: A phase IB/II study (KCSG BR18-16). Eur J Cancer 2023;195:113386.
PMID: 37890351
|
|
|
|